In support of this finding, rare and common variants in GCH1, the most common genetic cause of DOPA-responsive dystonia, have also been shown to increase the risk of Parkinson’s disease (Mencacci et al., 2014; Nalls et al., 2019). This evidence concerns the gene GCH1 and Dystonia.